SRx Health Solutions Inc. (SRXH)
NYSEAMERICAN: SRXH · Real-Time Price · USD
0.5330
+0.0130 (2.50%)
May 13, 2025, 9:23 AM - Market open
SRx Health Solutions Income Statement
Financials in millions CAD. Fiscal year is October - September.
Millions CAD. Fiscal year is Oct - Sep.
FY 2023 | FY 2022 |
Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 |
Revenue | 161.55 | 127.94 |
Revenue Growth (YoY) | 26.27% | - |
Cost of Revenue | 129.48 | 109.56 |
Gross Profit | 32.07 | 18.38 |
Selling, General & Admin | 36.06 | 18.15 |
Operating Expenses | 43.96 | 19.99 |
Operating Income | -11.89 | -1.61 |
Interest Expense | -2.79 | -1.04 |
Earnings From Equity Investments | - | -0.25 |
Other Non Operating Income (Expenses) | -0.18 | 0.12 |
Pretax Income | -14.86 | -2.78 |
Income Tax Expense | 0.27 | 0.61 |
Net Income | -15.13 | -3.38 |
Net Income to Common | -15.13 | -3.38 |
Shares Outstanding (Basic) | 12 | 1 |
Shares Outstanding (Diluted) | 12 | 1 |
Shares Change (YoY) | 1659.27% | - |
EPS (Basic) | -1.22 | -4.80 |
EPS (Diluted) | -1.22 | -4.80 |
Free Cash Flow | 2.14 | 4.33 |
Free Cash Flow Per Share | 0.17 | 6.15 |
Gross Margin | 19.85% | 14.36% |
Operating Margin | -7.36% | -1.26% |
Profit Margin | -9.36% | -2.64% |
Free Cash Flow Margin | 1.32% | 3.38% |
EBITDA | -9.58 | -0.75 |
EBITDA Margin | -5.93% | -0.58% |
D&A For EBITDA | 2.31 | 0.87 |
EBIT | -11.89 | -1.61 |
EBIT Margin | -7.36% | -1.26% |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.